Around 10 million people globally live with the life-threatening virus HTLV-1, yet it remains a poorly understood disease ...

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

Feline infectious peritonitis (FIP), triggered by a mutated coronavirus in cats, mirrors Long COVID in humans, causing severe immune responses. While ...

Japanese researchers have developed artificial blood, potentially revolutionizing emergency medicine and addressing global ...

DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...

Advanced light microscopy techniques have come into their own — and are giving scientists a new understanding of human biology and what goes wrong in disease ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

WHITE CLOUD — The dog side of the Newaygo County Animal Shelter in White Cloud has been been placed under quarantine out of ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

The six-year study focused on cyproheptadine, the active compound in the antihistamine Periactin. Periactin is commonly ...